GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Covetrus Inc (NAS:CVET) » Definitions » Asset Turnover

Covetrus (Covetrus) Asset Turnover : 0.35 (As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Covetrus Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Covetrus's Revenue for the three months ended in Jun. 2022 was $1,217 Mil. Covetrus's Total Assets for the quarter that ended in Jun. 2022 was $3,434 Mil. Therefore, Covetrus's Asset Turnover for the quarter that ended in Jun. 2022 was 0.35.

Asset Turnover is linked to ROE % through Du Pont Formula. Covetrus's annualized ROE % for the quarter that ended in Jun. 2022 was -1.06%. It is also linked to ROA % through Du Pont Formula. Covetrus's annualized ROA % for the quarter that ended in Jun. 2022 was -0.47%.


Covetrus Asset Turnover Historical Data

The historical data trend for Covetrus's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covetrus Asset Turnover Chart

Covetrus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Asset Turnover
Get a 7-Day Free Trial 1.72 1.70 1.42 1.27 1.33

Covetrus Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.34 0.33 0.33 0.35

Competitive Comparison of Covetrus's Asset Turnover

For the Medical Distribution subindustry, Covetrus's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covetrus's Asset Turnover Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Covetrus's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Covetrus's Asset Turnover falls into.



Covetrus Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Covetrus's Asset Turnover for the fiscal year that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2021 )/( (Total Assets (A: Dec. 2020 )+Total Assets (A: Dec. 2021 ))/ count )
=4575/( (3496+3410)/ 2 )
=4575/3453
=1.32

Covetrus's Asset Turnover for the quarter that ended in Jun. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2022 )/( (Total Assets (Q: Mar. 2022 )+Total Assets (Q: Jun. 2022 ))/ count )
=1217/( (3470+3398)/ 2 )
=1217/3434
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Covetrus  (NAS:CVET) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Covetrus's annulized ROE % for the quarter that ended in Jun. 2022 is

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=-16/1516.5
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-16 / 4868)*(4868 / 3434)*(3434/ 1516.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=-0.33 %*1.4176*2.2644
=ROA %*Equity Multiplier
=-0.47 %*2.2644
=-1.06 %

Note: The Net Income data used here is four times the quarterly (Jun. 2022) net income data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Covetrus's annulized ROA % for the quarter that ended in Jun. 2022 is

ROA %(Q: Jun. 2022 )
=Net Income/Total Assets
=-16/3434
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-16 / 4868)*(4868 / 3434)
=Net Margin %*Asset Turnover
=-0.33 %*1.4176
=-0.47 %

Note: The Net Income data used here is four times the quarterly (Jun. 2022) net income data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Covetrus Asset Turnover Related Terms

Thank you for viewing the detailed overview of Covetrus's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Covetrus (Covetrus) Business Description

Traded in Other Exchanges
N/A
Address
7 Custom House Street, Portland, ME, USA, 04101
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe and the Asia Pacific (APAC) and Emerging Markets. The company's services include supply chain services, software solutions, and prescription management.
Executives
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Edward Mcnamara director C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Rebecca Ann Kidd officer: Head of Global Operations 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Matthew Malenfant officer: Chief Commercial Officer 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Andrew B. Coxhead officer: See Remarks C/O RR DONNELLEY, 111 SOUTH WACKER DRIVE, CHICAGO IL 60606
Dustin Finer officer: Chief People Officer 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Paul R. Fonteyne director C/O RESTORBIO, INC., 501 BOYLSTON STREET SUITE 6102, BOSTON MA 02116
Laura J Phillips officer: See Remarks 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Michael Ellis officer: See Remarks C/O HS SPINCO, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Timothy Ludlow officer: See Remarks C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
Georgina Wraight officer: See Remarks C/O COVETRUS, INC., 7 CUSTOM HOUSE STREET, PORTLAND ME 04101
David Stuart Hinton officer: See Remarks C/O HS SPINCO, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Providenti Anthony C. Jr. officer: See Remarks 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jamey S Seely officer: General Counsel and Secretary C/O GATES INDUSTRIAL CORPORATION PLC, 1144 FIFTEENTH STREET, SUITE 1400, DENVER CO 80202
Sandra E Peterson director 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417